Promoted Content
Promoted Content

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Loading...

All Data

Filters Filter refresh
×
FILTER DATA :
News Type filter
    Company filter
      Product Type filter
        Deal Size filter
          Upfront Payment filter
            refresh

            Product Type Full Screen

            Companies Full Screen

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): TR009

            Therapeutic Area: Oncology Product Name: ABL001

            Highest Development Status: Phase I Product Type: Large molecule

            Partner/Sponsor/Collaborator: Elpiscience

            Deal Size: $117.0 million Upfront Cash: $7.0 million

            Deal Type: Collaboration January 20, 2021

            Details:

            Elpiscience obtains the exclusive development and commercialization rights of TR009 for Greater China across all oncology indications and will lead the clinical development and commercialization to accelerate the path to approval of TR009 in its territory.